$1.8 5.3%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 9 0%
App downloads 40 -2.4%
Sentiment 100 6.4%
Webpage traffic 48,000 -11.8%
Employee Rating 85 0%
Google Trends -100%
Linkedin Employees 249 N/A
Patents 1 0%
4chan Mentions 0% N/A
Facebook Engagement 16 33.3%
Facebook followers 70,760 -0.1%
Stocktwits Mentions 28 211.1%
Stocktwits Subscribers 3,685 0.6%
Twitter Followers 8,637 0%
Youtube Subscribers 1,710 0%
Instagram Followers 7,810 -0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 80 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About DarioHealth

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.

Price $1.8
Target Price Sign up
Market Cap $50M
Dividend Yield 0
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '233.5M13M610,000-16M-14M
Q2 '236.2M15M2.1M-17M-13M
Q1 '236.1M15M3.2M-13M-11M
Q4 '226.2M13M2.7M-13M-11M
Q3 '226.6M16M1.8M-16M-14M

Insider Transactions

Raphael Erez filed to buy 30 shares at $1000.
May 8 '23
KAPLAN JON H. filed to buy 30 shares at $1000.
May 8 '23
Shaked Yoav filed to buy 40 shares at $1000.
May 8 '23
Matheis Dennis filed to buy 50 shares at $1000.
May 8 '23
Raphael Erez filed to sell 1,112,059 shares at $6.2.
January 18 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.